Cancer Vaccine Week
Susan Hasty, Publisher
Table of Contents . . . July 5th, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Cancer Vaccine Week | Other Publications
Cancer Vaccine - Folate-mediated targeting of T cells to tumors reviewed
Cancer Vaccine - Immunological therapies in lymphoproliferative disorders reviewed
Cancer Vaccine - Toll-like receptor signals needed to reverse regulatory CD8 tolerance
Cancer Vaccine - Tumor suppressor candidate protein in PTEN turnover identified
Immunology - Positive results reported for telomerase cancer vaccine clinical trial
Breast Cancer - Significant survival advantage reported in phase III trial of Theratope
Cancer Therapy - FDA grants fast track designation for MedPulser Electroporation Therapy System
Cancer Vaccine - T cells primed by DCs pulsed with hepatoma acid-eluted substances
Colorectal Cancer Vaccine - CTL precursor-oriented peptide vaccine promising for colorectal cancer
Genomics - PELP1 expression modulated by E2-ER pathway and PELP1 is an ER target gene
Immune Response - iTopia Epitope Discovery System launched for immune response prediction
Immunology - Trial launched for new kidney-cancer vaccine
Lung Cancer - Data from trial of EP-2101 released at ASCO
Melanoma - MDX-010 receives orphan drug designation
Oncology - U.S. perspective on toxicology approaches for oncology drugs reviewed
Pancreatic Cancer - Vaccine shows promise in advanced pancreatic cancer, data shows
Prostate Cancer - Final results of phase I/II trial of CG7870 reported
Prostate Cancer Vaccine - Tumor-associated antigens show promise for prostate cancer vaccines
Prostate Cancer Vaccine - Vaccine benefits some prostate cancer patients in biochemical relapse
Renal Cell Carcinoma - Oncophage cancer vaccine clinical findings announced
Small Cell Lung Cancer - IMC-BEC2 cancer vaccine trial did not meet primary endpoint
Vaccine Adjuvant - Flagellin fusion proteins induce specific immune responses
Vaccine Delivery - Epicutaneous CpG oligodeoxynucleotides with antigen promotes CTL
Vaccine Development - Merck, KGaA, returns Theratope rights
Vaccine Development - pH-sensitive toxins find application in vaccines and drug delivery
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
